Printed from https://fyi.org.nz./request/28616-under-40s-extent-of-co-prescribing-for-adhd-anxiety-depression on October 17, 2024 01:21

Under 40s - extent of co-prescribing for ADHD, anxiety, depression.

J Bruning made this Official Information request to Pharmaceutical Management Agency

Currently waiting for a response from Pharmaceutical Management Agency, they must respond promptly and normally no later than (details and exceptions).

From: J Bruning

Dear Pharmaceutical Management Agency,

Please supply the following memos/advice/reports including reports and data for the under 40s age group (this may be further segmented, e.g. by decade) for the years 2014-2024:

[1] Numbers of prescriptions for ADHD medication, anxiety medication and depression medication.

[2] Evaluations of incidence/ co-prescribing of ADHD medication, anxiety medication and depression medication.

[3] Numbers of prescriptions for T1/T2 diabetes.

[4] Information held by Pharmac concerning adverse events/side effects of ADHD medication, anxiety medication and depression medication, including from co-prescribing:
- From other medicines regulators
- Following reviews of the scientific literature
- Supplied by the industry applicant

Yours faithfully,

Jodie Bruning.

Link to this

From: Aashish Patel
Pharmaceutical Management Agency

Kia ora Jodie,

 

Thank you for your request for official information, which Pharmac
received on 2 October 2024. Our reference number for your request is:
2024-25-048.

 

You should receive a response from us on or before 31 October 2024. This
is within the 20 working day limit set out in the Official Information
Act.

 

Please contact us if you have any questions.

 

Ngā mihi,

Government Services | Pharmac

show quoted sections

Link to this

Things to do with this request

Anyone:
Pharmaceutical Management Agency only: